AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-158710828/teva-sues-5-indian.html" title="Facts and information about TEVA SUES 5 INDIAN DRUG COMPANIES OVER PATENT RIGHTS (that protect a method of making anti-depressant drug setraline hydrochloride up to 2023).">TEVA SUES 5 INDIAN DRUG COMPANIES OVER PATENT RIGHTS (that protect a method of making anti-depressant drug setraline hydrochloride up to 2023).</a>
Close
Set up an RSS feed that alerts you when new articles from India Business Insight are available.
Frequently asked questions about RSS feeds
TEVA SUES 5 INDIAN DRUG COMPANIES OVER PATENT RIGHTS (that protect a method of making anti-depressant drug setraline hydrochloride up to 2023).
(From India Business Insight)
Teva Pharmaceutical Industries of Israel has sued Cipla, Zydus Cadila Healthcare, Lupin, Hetero Drugs and Torrent Pharmaceuticals for allegedly infringing on its patents that protect a method of making anti-depressant drug setraline hydrochloride up to 2023. Teva's drug is a copy of Pfizer's product sold as Zoloft and …
Related articles from newspapers, magazines, journals, and more
